NEW YORK (GenomeWeb) – The Damon Runyon Cancer Research foundation said today it has awarded $4 million to fund 10 researchers engaged in molecular and cellular research aimed at treating various types of cancer.

The new grants include seven new Damon Runyon Clinical Investigators awards, which provide $450,000 to early-career physician-scientists working under mentors at major research centers, and three Continuation Grants of $300,000 to researchers who are conducting promising research or clinical trials but are nearing the end of their initial awards.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.